Financhill
Buy
74

ALTM Quote, Financials, Valuation and Earnings

Last price:
$5.67
Seasonality move :
0%
Day range:
$5.70 - $5.73
52-week range:
$2.19 - $6.20
Dividend yield:
0%
P/E ratio:
34.19x
P/S ratio:
6.19x
P/B ratio:
0.97x
Volume:
107.2M
Avg. volume:
14.2M
1-year change:
-16.42%
Market cap:
$6.1B
Revenue:
$882.5M
EPS (TTM):
$0.17

Analysts' Opinion

  • Consensus Rating
    Arcadium Lithium PLC has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 18 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $6.09, Arcadium Lithium PLC has an estimated upside of 6.8% from its current price of $5.70.
  • Price Target Downside
    According to analysts, the lowest downside price target is $4.31 representing 24.39% downside risk from its current price of $5.70.

Fair Value

  • According to the consensus of 22 analysts, Arcadium Lithium PLC has 6.8% upside to fair value with a price target of $6.09 per share.

ALTM vs. S&P 500

  • Over the past 5 trading days, Arcadium Lithium PLC has overperformed the S&P 500 by 11.57% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Arcadium Lithium PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Arcadium Lithium PLC revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Arcadium Lithium PLC reported revenues of $203.1M.

Earnings Growth

  • Arcadium Lithium PLC earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Arcadium Lithium PLC reported earnings per share of $0.01.
Enterprise value:
7.6B
EV / Invested capital:
--
Price / LTM sales:
6.19x
EV / EBIT:
42.15x
EV / Revenue:
8.39x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-7.63x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
28.54x
Gross Profit (TTM):
$308M
Return On Assets:
2.2%
Net Income Margin (TTM):
17.22%
Return On Equity:
3.08%
Return On Invested Capital:
2.8%
Operating Margin:
7.53%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $716.7M $920.1M $900.6M $211.4M $203.1M
Gross Profit $318.2M $555M $308M $127.8M $56.2M
Operating Income $258.5M $488.7M $190.5M $113.3M $15.3M
EBITDA $281.4M $517.3M $264.7M $121M $44.3M
Diluted EPS $0.33 $0.74 $0.17 $0.17 $0.01
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $253.6M $432.3M $573.9M $478.2M $865.6M
Total Assets $903.1M $1.2B $2B $2.4B $10B
Current Liabilities $78.2M $88.7M $163M $138.3M $735.3M
Total Liabilities $336.5M $366.5M $652.7M $620.5M $2.9B
Total Equity $566.6M $784.5M $1.4B $1.7B $7.1B
Total Debt $224.1M $240.1M $255.1M $243.1M $724.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $313.6M $388.3M -$123.4M $80.2M -$39.2M
Cash From Investing -$294.7M -$454.5M -$42.6M -$135.3M -$288.2M
Cash From Financing $100K -$33M $204.2M $100K $83.5M
Free Cash Flow $22.8M $40.3M -$989.8M -$1.4M -$278.2M
ALTM
Sector
Market Cap
$6.1B
$19.1M
Price % of 52-Week High
91.94%
59.67%
Dividend Yield
0%
0%
Shareholder Yield
--
1.61%
1-Year Price Total Return
-16.42%
-16.13%
Beta (5-Year)
--
1.047
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $5.25
200-day SMA
Buy
Level $4.09
Bollinger Bands (100)
Buy
Level 3.02 - 5.6
Chaikin Money Flow
Sell
Level -494.6M
20-day SMA
Buy
Level $5.14
Relative Strength Index (RSI14)
Buy
Level 72.09
ADX Line
Buy
Level 26.87
Williams %R
Sell
Level -3.2609
50-day SMA
Buy
Level $5.23
MACD (12, 26)
Buy
Level 0.07
25-day Aroon Oscillator
Buy
Level 44
On Balance Volume
Sell
Level -183.5M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
Buy
CA Score (Annual)
Level (0.824)
Buy
Beneish M-Score (Annual)
Level (-2.2715)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-2.3831)
Buy
Piotroski F Score (Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Arcadium Lithium is a pure-play lithium producer that was formed by the Allkem-Livent merger in January 2024. The company agreed to a deal for Arcadium to be acquired by Rio Tinto in an all-cash transaction that should close in 2025. Arcadium should benefit from increased lithium demand via higher electric vehicle adoption, as lithium is a key component of EV batteries. The company's low-cost lithium carbonate production comes from two brine resources in Argentina. Arcadium also produces spodumene, a hard rock lithium upstream concentrate, from a mine in Australia and operates downstream lithium hydroxide conversion plants in the United States and China.

Stock Forecast FAQ

In the current month, ALTM has received 4 Buy ratings 18 Hold ratings, and 0 Sell ratings. The ALTM average analyst price target in the past 3 months is $6.09.

  • Where Will Arcadium Lithium PLC Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Arcadium Lithium PLC share price will rise to $6.09 per share over the next 12 months.

  • What Do Analysts Say About Arcadium Lithium PLC?

    Analysts are divided on their view about Arcadium Lithium PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arcadium Lithium PLC is a Sell and believe this share price will drop from its current level to $4.31.

  • What Is Arcadium Lithium PLC's Price Target?

    The price target for Arcadium Lithium PLC over the next 1-year time period is forecast to be $6.09 according to 22 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 18 analysts rate the stock a Hold.

  • Is ALTM A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Arcadium Lithium PLC is a Hold. 18 of 22 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of ALTM?

    You can purchase shares of Arcadium Lithium PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arcadium Lithium PLC shares.

  • What Is The Arcadium Lithium PLC Share Price Today?

    Arcadium Lithium PLC was last trading at $5.67 per share. This represents the most recent stock quote for Arcadium Lithium PLC. Yesterday, Arcadium Lithium PLC closed at $5.70 per share.

  • How To Buy Arcadium Lithium PLC Stock Online?

    In order to purchase Arcadium Lithium PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 7.07% over the past day.

Sell
47
CEG alert for Jan 10

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
8
CRNX alert for Jan 10

Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock